Stabilitech Ltd
Company Profile:
Stabilitech Ltd. has developed a novel proprietary technology which stabilizes vaccines and other biological products. Currently, vaccines and biopharmaceuticals require storage and transport under strictly controlled temperatures. Stabilitech’s technology will enable the long term stable storage of vaccines and other biological products over a wide range of temperatures. The technology has been successfully applied to live viral vaccines, inactivated viruses and sub-unit vaccines as well as to other biological products. Stabilitech’s approach involves the addition of carefully selected excipients at optimized concentrations and ratios, followed by freeze drying.
Key Products:
Stabilitech offers formulation of vaccines and biopharmaceuticals to a wide range of clients.
Website:
www.stabilitech.com
